12-month outcomes of the US patient cohort in the SONATA pivotal IDE trial of transcervical ablation of uterine fibroids

OBJECTIVE: The prospective SONATA pivotal Investigational Device Exemption (IDE) trial was performed in the United States (US) and Mexico to examine the safety and effectiveness of transcervical fibroid ablation (TFA) in the treatment of symptomatic uterine fibroids. This is an analysis of 12-month...

Descripción completa

Detalles Bibliográficos
Autores principales: Hudgens, Joseph, Johns, D Alan, Lukes, Andrea S, Forstein, David A, Delvadia, Dipak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6616301/
https://www.ncbi.nlm.nih.gov/pubmed/31308763
http://dx.doi.org/10.2147/IJWH.S201912

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6616301/
https://www.ncbi.nlm.nih.gov/pubmed/31308763
http://dx.doi.org/10.2147/IJWH.S201912

Ejemplares similares